Malaria battle boost

نویسنده

  • Nigel Williams
چکیده

Microsoft founder, Bill Gates, pledged more than $160 million from his charitable foundation to help develop vaccines for malaria as part of a package of funds totalling $3 billion revealed at a meeting at the UN to assess progress in the Millennium Development Goals to halve global poverty by 2015. Gates said that his funds would be for the PATH Malaria Vaccine Initiative (MVI), in conjunction with the pharmaceutical company, GlaxoSmithKline. The plan is to support 'next generation' vaccines to find longer-lasting protection against the parasite. " I'm very hopeful that the malaria vaccine currently in advanced testing will be proven effective, but that will just be the first step, " said Gates. " Now is the time to develop a new generation of vaccines that are even more effective and could someday help eradicate malaria altogether. " Christian Loucq, director of the MVI, said the current vaccine, known as RTS,S, could be available by 2013 if it is swiftly approved by the European licensing authority and then the WHO, as seems likely. But the money from the Gates Foundation is aimed at accelerating development of an even better vaccine. The MVI has entered into a number of collaborative agreements in the past few months in an effort to boost development. It is now working with the Walter and Eliza Hall Institute in Melbourne in an effort to isolate and evaluate particular antigens from the parasite that could be used in a vaccine. The MVI is also working with the Infectious Diseases Research Institute to develop new adjuvants for future vaccines and with the Seattle Biomedical Research Institute to help develop a 'human challenge center' devoted exclusively to testing the safety and efficacy of malaria vaccines. " These new funds are recognition that we have a solid strategy in place to accelerate further malaria vaccine development — and the team to deliver on it, " said Loucq. The World Bank said it would increase spending on fighting malaria in Africa by $1.1 billion, and focus on the Democratic Republic of Congo and Nigeria, which account for 30–40 per cent of malaria deaths worldwide. The bank's president, Robert Zoelick, said some African countries had made progress in cutting malaria deaths through the distribution of bednets and more access to low-cost, effective drugs for treating the disease. The Geneva-based Global Fund to fight AIDS, Tuberculosis and Malaria also said at the meeting …

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys.

A vaccine that elicits both specific antibodies and IFN-gamma-producing T cells is required to protect against pre-erythrocytic malaria. Among the most promising approaches to induce such complex immunity are heterologous prime-boost vaccination regimens, in particular ones containing live viral vector. We have demonstrated previously that adenovectors serotype 35 (Ads35) encoding the circumspo...

متن کامل

Sex: How Malaria Parasites Get Turned On

The mechanisms underlying sexual stage switching in Plasmodium spp. have hitherto remained a mystery. However, two recent studies have revealed that an apicomplexan-specific DNA-binding protein is essential for the initiation of this cell fate decision, ultimately providing the malaria community with a novel and important tool in the battle to prevent malaria transmission.

متن کامل

WHO EMRO | WHO events addressing public health priorities: Prevention of re-establishment of local malaria transmission in malaria-free countries

The battle to eliminate the scourge of malaria in the Eastern Mediterranean Region (EMR) continues unabated. To date there have been notable successes in this fight, with 14 countries so far having succeeded in eliminating malaria (1). Their main priority now is to prevent re-establishment of local malaria transmission in receptive and vulnerable areas. However, local malaria outbreaks have bee...

متن کامل

DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity

BACKGROUND Gene-based vaccination using prime/boost regimens protects animals and humans against malaria, inducing cell-mediated responses that in animal models target liver stage malaria parasites. We tested a DNA prime/adenovirus boost malaria vaccine in a Phase 1 clinical trial with controlled human malaria infection. METHODOLOGY/PRINCIPAL FINDINGS The vaccine regimen was three monthly dos...

متن کامل

Sterile Protection against Plasmodium knowlesi in Rhesus Monkeys from a Malaria Vaccine: Comparison of Heterologous Prime Boost Strategies

Using newer vaccine platforms which have been effective against malaria in rodent models, we tested five immunization regimens against Plasmodium knowlesi in rhesus monkeys. All vaccines included the same four P. knowlesi antigens: the pre-erythrocytic antigens CSP, SSP2, and erythrocytic antigens AMA1, MSP1. We used four vaccine platforms for prime or boost vaccinations: plasmids (DNA), alphav...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Current Biology

دوره 18  شماره 

صفحات  -

تاریخ انتشار 2008